BioTuesdays

Category - Markets

Heat Biologics
Markets

HCW starts Heat Biologics at buy; PT $6

H.C. Wainwright launched coverage of Heat Biologics (NASDAQ:HTBX) with a “buy” rating and $6 price target. The stock closed at $2.22 on June 25. The company’s immunotherapy approach for the treatment of tumors is...

June 26, 2018
Soleno Therapeutics Logo
Markets

Roth starts Soleno Therapeutics at buy; PT $14

Roth Capital Partners initiated coverage of Soleno Therapeutics (NASDAQ:SLNO) with a “buy” rating and $14 price target. The stock closed at $2.32 on June 21. Soleno’s focus is on Prader-Wili Syndrome (PWS), a rare...

June 22, 2018
Evofem Biosciences Logo
Markets

Roth starts Evofem Biosciences at buy; PT $15

Roth Capital Partners initiated coverage of Evofem Biosciences (NASDAQ:EVFM) with a “buy” rating and $15 price target. The stock closed at $3.30 on June 19. Analyst Yasmeen Rahimi writes that the time is ripe for...

June 20, 2018
Neptune Wellness Solutions Logo
Markets

Echelon ups Neptune Wellness PT to $8

Echelon Wealth Partners hiked its price target for Neptune Wellness Solutions (TSX, NASDAQ:NEPT) to $8 from $5.25 after the company struck a strategic medical cannabis oil agreement with Canopy Growth (TSX:WEED). Shares...

June 19, 2018
Arcadia Logo
Markets

HCW starts Arcadia Biosciences at buy; PT $20

H.C. Wainwright initiated coverage of Arcadia Biosciences (NASDAQ:RKDA) with a “buy” rating and $20 price target. The stock closed at $8.16 on June 18. Arcadia has a track record in the generation of productivity traits...

June 19, 2018
Helius Medical Technologies Logo
Markets

BTIG cuts Helius Medical to neutral; PT $14

BTIG downgraded Helius Medical Technologies (NASDAQ:HSDT) to “neutral” from “buy” but maintained its $14 price target, saying it is uneasy about regulatory and fundraising timelines. The stock closed at $12.87 on June...

June 19, 2018
CareDx Logo
Markets

HCW cuts CareDx to neutral but ups PT to $15

H.C. Wainwright downgraded CareDx (NASDAQ:CDNA) to “neutral” from “buy” but raised its price target to $15 from $14, citing the company’s valuation. The stock closed at $15.78 on June 18. Earlier this month, CareDx held...

June 19, 2018
Iterum Therapeutics Logo
Markets

Leerink starts Iterum Therapeutics at OP; PT $18

Leerink launched coverage of Iterum Therapeutics (NASDAQ:ITRM) with an “outperform” rating and price target of $18. The stock closed at $12 on June 18. Iterum is developing an IV and oral formulation of sulopenem for...

June 19, 2018
Flex Pharma
Markets

Ladenburg cuts Flex Pharma to neutral, drops PT

Ladenburg Thalmann downgraded Flex Pharm (NASDAQ:FLKS) to “neutral” from “buy” without a price target after the company halted two Phase 2 trials. In afternoon trading on June 13, shares of Flex were quoted at $1.36...

June 13, 2018